FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

377381003: Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3681519012 Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3681520018 Acetaminophen 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral capsule en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3681521019 Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral capsule en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
1202699010 Acetaminophen + phenyltoloxamine citrate + salicylamide 300mg/20mg/200mg capsule (product) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
1215588019 Acetaminophen + phenyltoloxamine citrate + salicylamide 300mg/20mg/200mg capsule en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
1215588019 Acetaminophen + phenyltoloxamine citrate + salicylamide 300mg/20mg/200mg capsule en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
1478744012 Acetaminophen+phenyltoloxamine citrate+salicylamide 300mg/20mg/200mg capsule en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
2820832014 Paracetamol + phenyltoloxamine citrate + salicylamide 300mg/20mg/200mg capsule en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
3469707018 Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg/1 each oral capsule en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3469708011 Acetaminophen 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg/1 each oral capsule en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3469709015 Product containing acetaminophen 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg/1 each oral capsule en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3469710013 Product containing paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg/1 each oral capsule en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3490467019 Product containing paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg/1 each oral capsule (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3569299017 Product containing only paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg/1 each oral capsule (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3569300013 Product containing only acetaminophen 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg/1 each oral capsule en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3569301012 Product containing only paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg/1 each oral capsule en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3681519012 Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3681520018 Acetaminophen 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral capsule en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3681521019 Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral capsule en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3681522014 Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) Is a Product containing phenyltoloxamine (medicinal product) false Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) Is a Acetaminophen compound preparation false Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Ethanolamine false Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Sedating antihistamine false Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Non-opioid analgesics false Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Phenyltoloxamine false Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) Is a Product containing paracetamol and phenyltoloxamine citrate and salicylamide false Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Phenyltoloxamine citrate false Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Salicylamide false Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Paracetamol false Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) Has manufactured dose form A solid single-dose form that is a shell made of gelatin or other substances. The contents of the shell may be a solid, semi-solid or liquid. false Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. agent cardiovasculaire false Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) Has manufactured dose form Oral capsule true Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) Is a Product containing paracetamol in oral dose form (medicinal product form) false Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Paracetamol false Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) Has basis of strength substance (attribute) Paracetamol false Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength numerator value 300 false Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength numerator unit (attribute) mg true Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value un false Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator unit (attribute) Capsule (unit of presentation) true Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength numerator unit (attribute) mg true Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value un false Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator unit (attribute) Capsule (unit of presentation) true Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength numerator unit (attribute) mg true Inferred relationship Existential restriction modifier (core metadata concept) 3
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value un false Inferred relationship Existential restriction modifier (core metadata concept) 3
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator unit (attribute) Capsule (unit of presentation) true Inferred relationship Existential restriction modifier (core metadata concept) 3
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Phenyltoloxamine citrate false Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) Has basis of strength substance (attribute) Phenyltoloxamine citrate false Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength numerator value 20 false Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Salicylamide false Inferred relationship Existential restriction modifier (core metadata concept) 3
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) Has basis of strength substance (attribute) Salicylamide false Inferred relationship Existential restriction modifier (core metadata concept) 3
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength numerator value 200 false Inferred relationship Existential restriction modifier (core metadata concept) 3
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) Has precise active ingredient Salicylamide false Inferred relationship Existential restriction modifier (core metadata concept) 3
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) Has unit of presentation Capsule (unit of presentation) true Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) Has precise active ingredient Phenyltoloxamine citrate false Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) Has precise active ingredient Paracetamol false Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) Is a Paracetamol- and phenyltoloxamine- and salicylamide-containing product in oral dose form false Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient trois false Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) Is a Paracetamol and phenyltoloxamine and salicylamide only product in oral dose form true Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) Has basis of strength substance (attribute) Salicylamide true Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) Has basis of strength substance (attribute) Phenyltoloxamine citrate true Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) Has precise active ingredient Paracetamol true Inferred relationship Existential restriction modifier (core metadata concept) 3
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) Has precise active ingredient Salicylamide true Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) Has basis of strength substance (attribute) Paracetamol true Inferred relationship Existential restriction modifier (core metadata concept) 3
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) Has precise active ingredient Phenyltoloxamine citrate true Inferred relationship Existential restriction modifier (core metadata concept) 1

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start